Skip to content
OpenCapital
Get started

Bioventus BVS EPS (Diluted)

EPS (Diluted) at other companies

Stryker logo
StrykerSYK
$1.93+14.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.22+34.1%
Medtronic logo
MedtronicMDT
$0.97+18.3%
Avanos Medical logo
Avanos MedicalAVNS
$0.11-21.4%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$0.22+37.1%
Enovis logo
EnovisENOV
-$0.15+84.7%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×—
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%—
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's EPS (diluted)?
Bioventus (BVS) reported EPS (diluted) of $0.04 in Q1 2026.
How has Bioventus's EPS (diluted) changed year-over-year?
Bioventus's EPS (diluted) increased by 200.0% year-over-year, from -$0.04 to $0.04.
What is the long-term trend for Bioventus's EPS (diluted)?
Over 4 years (2021 to 2025), Bioventus's EPS (diluted) has grown at a 2.4% compound annual growth rate (CAGR), from -$0.30 to $0.33.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.